SCHEMBL4072965

SCHEMBL4072965

CC(C)(C)c1ccc(S(=O)(=O)Nc2cnc3[nH]c(OC(=O)O)c(-c4ccoc4)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
BRD4 O60885 1/20 0.40
HIF1A Q16665 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 2/20 0.40
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR6 P50406 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SERPINE1 P05121 1/20 0.40
UQCRB P14927 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4067709 0.89 SERPINE1 (0.49) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4072961 0.88 PTPN5 (0.45) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4077705 0.86 PTPN5 (0.41) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4073082 0.82 SERPINE1 (0.48) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4069882 0.82 BRD4 (0.42) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4072264 0.80 EDNRB (0.46) PTPN5LMNAHIF1AMEN1KMT2A
SCHEMBL4392130 0.80 SERPINE1 (0.47) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4070333 0.80 FABP1 (0.45) ALDH1A1KDM4EPOLBHTR1AHTR1D
SCHEMBL4067259 0.78 SERPINE1 (0.46) PTPN5ALDH1A1KDM4ELMNABRD4
SCHEMBL4137983 0.78 HTR1A (0.37) PTPN5ALDH1A1KDM4ELMNABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2036906-A1 Azaindoles as inhibitors of soluble adenylate cyclase Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-18 EP disclosed